Improvement of gram-negative susceptibility to fluoroquinolones after implementation of a pre-authorization policy for fluoroquinolone use: A decade-long experience

Authors: Lee, Rachael A., Scully, Morgan C., Camins, Bernard C., Griffin, Russell L., Kunz, Danielle F., Moser, Stephen A., Hoesley, Craig J., McCarty, Todd P., Pappas, Peter G.

Source: Infection control and hospital epidemiology. 39(12):1419-1424

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN620526609&indx=1&recIds=ETOCRN620526609

Association between Vancomycin-Resistant Enterococci Bacteremia and Ceftriaxone Usage

Authors: McKinnell, James A., Kunz, Danielle F., Chamot, Eric, Patel, Mukesh, Shirley, Rhett M., Moser, Stephen A., Baddley, John W., Pappas, Peter G., Miller, Loren G.

Source: Infection Control and Hospital Epidemiology, 2012 Jul 01. 33(7), 718-724.

Access URL: https://www.jstor.org/stable/10.1086/666331

Initial management of candidemia at an academic medical center: Evaluation of the IDSA guidelines

Authors: Patel, Mukesh¹, Kunz, Danielle F.², Trivedi, Vivek M.¹, Jones, Marga G.¹, Moser, Stephen A.³, Baddley, John W.^1,4 jbaddley@uab.edu

Source: Diagnostic Microbiology & Infectious Disease. May2005, Vol. 52 Issue 1, p29-34. 6p.

Subject Terms: *COMMUNICABLE diseases, *FUNGICIDES, *ANTI-infective agents, *CANDIDIASIS